Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drug Safety
Metadata
Title
Safety of Selegiline (Deprenyl) in the Treatment of Parkinson’s Disease
Authors
Dr Esa Heinonen
Vilho Myllylä
Publication date
01-07-1998
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 1/1998
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199819010-00002

Other articles of this Issue 1/1998

Drug Safety 1/1998 Go to the issue

Review Article

Drug-Induced Bladder and Urinary Disorders

Review Article

Choosing the Most Appropriate Treatment for Stable Angina

Review Article

Managing Antipsychotic-Induced Acute and Tardive Dystonia

Leading Article

The Role of the WHO Programme on International Drug Monitoring in Coordinating Worldwide Drug Safety Efforts

Review Article

Neuroleptic Malignant Syndrome